Saul N Faust Selected Research

COVID-19

1/2024	Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
1/2024	Vaccination against COVID-19 - risks and benefits in children.
12/2023	Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents.
1/2023	Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.
12/2022	Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial.
11/2022	Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
2/2022	Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial.
1/2022	Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial.
1/2022	Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
12/2021	Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Saul N Faust Research Topics

Disease

33	Infections 02/2023 - 10/2011
20	COVID-19 01/2024 - 01/2020
9	Malaria 11/2021 - 12/2012
7	Human Influenza (Influenza) 01/2020 - 12/2010
7	Sepsis (Septicemia) 01/2020 - 08/2004
6	Fever (Fevers) 01/2023 - 10/2011
6	Pneumococcal Infections 01/2017 - 10/2011
5	Inflammation (Inflammations) 01/2024 - 09/2006
5	Pain (Aches) 11/2022 - 12/2014
5	Bacterial Infections (Bacterial Infection) 01/2022 - 01/2016
5	Pneumonia (Pneumonitis) 11/2021 - 01/2017
5	Whooping Cough (Pertussis) 01/2020 - 12/2010
4	Respiratory Tract Infections (Respiratory Tract Infection) 12/2023 - 12/2015
4	Persistent Infection 12/2020 - 01/2017
4	Cystic Fibrosis (Mucoviscidosis) 01/2020 - 12/2015
4	Diphtheria 01/2020 - 10/2011
4	Bites and Stings (Sting) 01/2018 - 12/2012
3	Dyspnea (Shortness of Breath) 01/2023 - 01/2021
3	Meningococcal Infections 12/2022 - 07/2010
3	Virus Diseases (Viral Diseases) 01/2022 - 12/2015
3	Cough 11/2021 - 01/2021
3	Tetanus 01/2020 - 02/2015
3	Septic Shock (Toxic Shock Syndrome) 01/2020 - 01/2014
3	Pseudomonas Infections 01/2017 - 12/2015
2	Myocarditis (Carditis) 01/2024 - 01/2016
2	COVID-19 related pediatric multisystem inflammatory disease 01/2022 - 01/2021
2	Headache (Headaches) 12/2021 - 01/2020
2	Parasitemia 11/2021 - 06/2016
2	Ageusia (Hypogeusia) 10/2021 - 01/2021
2	Anosmia 10/2021 - 01/2021
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2020 - 01/2020
2	Communicable Diseases (Infectious Diseases) 04/2020 - 01/2019
2	Poliomyelitis (Polio) 01/2018 - 02/2015
2	Osteomyelitis 01/2017 - 06/2008
2	Lymphopenia (Lymphocytopenia) 01/2017 - 11/2016
1	Cytomegalovirus Infections (Inclusion Disease) 02/2024
1	Sensorineural Hearing Loss 02/2024
1	Respiratory Syncytial Virus Infections 07/2023
1	Breakthrough Infections 12/2022
1	Neoplasms (Cancer) 01/2022
1	Fatigue 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Hepatitis B 10/2021

Drug/Important Bio-Agent (IBA)

43	VaccinesIBA 01/2024 - 12/2010
18	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 06/2008
9	ChAdOx1 nCoV-19IBA 01/2023 - 01/2020
8	Conjugate VaccinesIBA 12/2022 - 10/2011
8	AntigensIBA 01/2022 - 12/2010
6	Amoxicillin (Wymox)FDA LinkGeneric 01/2023 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2015
5	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 11/2021 - 04/2015
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2020 - 03/2014
5	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2020 - 03/2012
4	AntibodiesIBA 12/2023 - 07/2012
3	Messenger RNA (mRNA)IBA 01/2024 - 01/2022
3	Immunoglobulin G (IgG)IBA 02/2023 - 12/2010
3	MenACWYIBA 12/2022 - 01/2020
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
3	Nucleic AcidsIBA 10/2021 - 01/2021
3	ProdrugsIBA 01/2020 - 01/2017
3	CytokinesIBA 10/2017 - 02/2012
2	mRNA VaccinesIBA 01/2024 - 02/2022
2	Oxygen (Dioxygen)IBA 12/2023 - 02/2021
2	Meningococcal Vaccines (Meningococcal Vaccine)IBA 11/2022 - 01/2018
2	RNA (Ribonucleic Acid)IBA 02/2022 - 08/2016
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 01/2021
2	Methylprednisolone FDA LinkGeneric 01/2022 - 01/2021
2	COVID-19 VaccinesIBA 01/2022 - 01/2021
2	Infliximab (Remicade)FDA Link 01/2021 - 10/2017
2	Cephalosporins (Cephalosporin Antibiotics)IBA 12/2020 - 01/2020
2	ThrombospondinsIBA 01/2018 - 09/2016
2	Complement System Proteins (Complement)IBA 01/2018 - 07/2010
2	Azithromycin (Zithromax)FDA LinkGeneric 01/2017 - 01/2017
2	Malaria VaccinesIBA 09/2016 - 12/2012
2	Combined VaccinesIBA 02/2015 - 01/2015
1	Antiviral Agents (Antivirals)IBA 02/2024
1	Valganciclovir FDA Link 02/2024
1	Dimethyl FumarateIBA 01/2024
1	InflammasomesIBA 01/2024
1	Monoclonal AntibodiesIBA 12/2023
1	nirsevimabIBA 12/2023
1	serogroup C meningococcal conjugate vaccineIBA 12/2022
1	Ad26COVS1IBA 12/2022
1	Phosphates (Orthophosphate)IBA 12/2022
1	Lipid NanoparticlesIBA 02/2022
1	ProcalcitoninIBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Anti-Idiotypic AntibodiesIBA 10/2021

Therapy/Procedure

13	Therapeutics 02/2024 - 06/2012
2	Length of Stay 01/2022 - 01/2016
2	Resuscitation 01/2020 - 01/2020
2	Surgical Amputation (Amputations) 01/2017 - 08/2004
2	Critical Care (Surgical Intensive Care) 01/2017 - 08/2016
1	Injections 12/2022
1	Duration of Therapy 11/2021